Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial
This product ships lyophilised (freeze-dried) to remain stable throughout transit and storage
When first starting treatment, some patients experience stomach cramping or nausea, while others can also have vomiting or diarrhea
Providers must be vigilant to minimize and treat any GI symptoms that arise, she concludes
Chitosan-coated flexible liposomes magnify the anticancer activity and bioavailability of docetaxel: impact on composition
A conversion chart can help guide this transition, though individual responses vary significantly
US$ 28.90
US$ 22.62
US$ 28.28
US$ 22.26
US$ 20.30
US$ 28.80
US$ 24.04
US$ 21.61
US$ 21.11
